Kezar Life Sciences, Inc. (KZR) Treasury Shares (2017 - 2025)

Kezar Life Sciences has reported Treasury Shares for 8 years, with the latest figure at $497.0 in Q4 2025.

• Quarterly Treasury Shares fell 95.45% year-over-year to $497.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $497.0 (down 95.45% YoY) and the FY2025 annual result came in at $497.0, down 95.45% from the prior year.
• Treasury Shares retreated to $497.0 in Q4 2025 per KZR's latest filing, from $1127.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $483276.0 in Q1 2023 and troughed at $497.0 in Q4 2025.
• A 4-year average of $163972.4 and a median of $41935.0 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares soared 1052.44% in 2023, then slumped 96.37% in 2024.
• Over 4 years, Treasury Shares stood at $434790.0 in 2022, then tumbled by 94.95% to $21945.0 in 2023, then sank by 50.26% to $10916.0 in 2024, then slumped by 95.45% to $497.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $497.0, $1127.0, and $8318.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.